The DOI matches its Crossref record.
Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor Activity
Abstract
Surgical adjuvant intravesical bacille Calmette-Guerin (BCG) therapy is an effective method of treating superficial transitional cell carcinoma of the bladder. The role of the immune response in the antitumor activity of intravesical BCG is not known. We investigated the requirement of a thymus-dependent immune response for the inhibition of the growth of the intravesically implanted mouse bladder tumor, MBT-2. Intravesical BCG had no antitumor activity when administered to athymic nude mice bearing MBT-2 tumors. In two experiments tumor outgrowth in control and BCG-treated mice was identical. Adoptive transfer of BCG sensitized splenocytes (one spleen equivalent per mouse injected intravenously immediately prior to the first BCG treatment) syngeneic to the MBT-2 tumor transferred delayed hypersensitivity reactivity to BCG antigens and restored the antitumor activity of intravesical BCG. In two separate experiments mice receiving splenocytes plus BCG had 0 and 20% tumor outgrowth compared with 100% in control mice (p less than .02 and p less than .05, respectively). These results demonstrate that the antitumor activity of intravesical BCG therapy requires a thymus-dependent immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The mechanism of action of BCG therapy for bladder cancer--a current perspective
Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.15 · Cited by 729
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
Pettenati, C., & Ingersoll, M. A. (2018) · Nature Reviews Urology · doi:10.1038/s41585-018-0055-4 · Cited by 457
Immune Mechanisms in Bacillus Calmette-Guerin Immunotherapy for Superficial Bladder Cancer
BÖHLE, A., & BRANDAU, S. (2003) · Journal of Urology · doi:10.1097/01.ju.0000073852.24341.4a · Cited by 318
T-Cell Subsets Required for Intravesical BCG Immunotherapy for Bladder Cancer
Ratliff, T. L., Ritchey, J. K., Yuan, J. J. J., Andriole, G. L., & Catalona, W. J. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35678-1 · Cited by 283
Self-citationDiPaola, R. S., & Lattime, E. C. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.08.063 · Cited by 282
Metadata
- Authors
- Ratliff, T. L., Gillen, D., & Catalona, W. J.
- Venue
- Journal of Urology
- Published
- 1987-01
- Volume
- 137
- Issue
- 1
- Pages
- 155-158
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W229763590
- Cited by
- 225
- References
- 0
- FWCI
- 11.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor Activity. https://app.cochat.ai/papers/10.1016/s0022-5347(17)43909-7
- The paper
- Ratliff, T. L., Gillen, D., & Catalona, W. J. (1987). Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor Activity. Journal of Urology. https://doi.org/10.1016/s0022-5347(17)43909-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.